Literature DB >> 27021541

Comparison of MMP2 and MMP9 expression levels between primary and metastatic regions of oral squamous cell carcinoma.

Kensuke Nishio1, Keiko Motozawa, Daisuke Omagari, Takahiro Gojoubori, Takayuki Ikeda, Masatake Asano, Nobuhito Gionhaku.   

Abstract

Matrix metalloproteinases (MMPs) and tumor-associated macrophages (TAMs) play important roles in tumor growth. The present study investigated the expression levels of MMP2 and MMP9 in relation to the distribution of TAMs in the primary and metastatic regions of oral squamous cell carcinoma. Twenty-nine cases of oral squamous cell carcinoma (OSCC) with regional lymph node metastasis were selected from available documents in the archives of the Department of Pathology, Nihon University School of Dentistry. Four-micrometer-thick sections were prepared from the primary and metastatic regions. Each section was subjected to immunohistochemical staining using anti-MMP2, anti-MMP9, and anti-CD68 antibodies. The distribution and localization of MMPs and TAMs were compared between primary and metastatic regions. The expression levels of both MMPs were higher in the metastatic regions of lingual and gingival cancers. Statistically significant differences were observed in both T1 and T2 cases. In contrast to the higher expression of MMPs in metastatic regions, a higher number of TAMs were distributed in the primary regions. From these results, MMP expression levels and the numbers of TAMs were expected to have an inverse relationship between the primary and metastatic regions of OSCC. (J Oral Sci 58, 59-65, 2016).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27021541     DOI: 10.2334/josnusd.58.59

Source DB:  PubMed          Journal:  J Oral Sci        ISSN: 1343-4934            Impact factor:   1.556


  9 in total

1.  Characterization of Copy Number Variations in Oral Cavity Squamous Cell Carcinoma Reveals a Novel Role for MLLT3 in Cell Invasiveness.

Authors:  Chun-I Wang; Huang-Kai Kao; Ting-Wen Chen; Yenlin Huang; Hsing-Wen Cheng; Jui-Shan Yi; Shao-Yu Hung; Chi-Sheng Wu; Yun-Shien Lee; Kai-Ping Chang
Journal:  Oncologist       Date:  2019-07-04

2.  Low expression of RECK in oral squamous cell carcinoma patients induces a shorter survival rate through an imbalance of RECK/MMPs.

Authors:  Jian Yuan; Wen Li; Jinxiao Zhu; Shuli Deng; Xuejin Tao
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

3.  CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis.

Authors:  Chengcheng Yang; Haochen Yu; Rui Chen; Kai Tao; Lei Jian; Meixi Peng; Xiaotian Li; Manran Liu; Shengchun Liu
Journal:  Int J Oncol       Date:  2019-07-15       Impact factor: 5.650

4.  Inhibiting the Progression of Human Retinoblastoma Cell by Downregulation of MMP-2/MMP-9 Using Short Hairpin RNAs (shRNAs) In Vitro.

Authors:  Nana Meng; Zhi Zhao; Chunhe Shi; Leizhou Xia
Journal:  J Ophthalmol       Date:  2020-05-13       Impact factor: 1.909

5.  A circular RNA derived from MMP9 facilitates oral squamous cell carcinoma metastasis through regulation of MMP9 mRNA stability.

Authors:  Bing Xia; Tao Hong; Xin He; Xinlan Hu; Yongbo Gao
Journal:  Cell Transplant       Date:  2019-09-11       Impact factor: 4.064

Review 6.  The Role of RECK in Hepatobiliary Neoplasia Reveals Its Therapeutic Potential in NASH.

Authors:  Ryan J Dashek; Connor Diaz; Bysani Chandrasekar; R Scott Rector
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-20       Impact factor: 5.555

7.  Evaluation of matrix metalloproteinase 9 gene expression in oral squamous cell carcinoma and its clinicopathological correlation.

Authors:  Krishnapriya Umashankar; Gifrina Jayaraj; Herald J Sherlin; K R Don; Archana Santhanam
Journal:  Natl J Maxillofac Surg       Date:  2021-12-13

8.  The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC.

Authors:  Lin-Hong Wang; Mei Xu; Luo-Qin Fu; Xiao-Yi Chen; Fan Yang
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

9.  CircRASSF2 acts as a prognostic factor and promotes breast cancer progression by modulating miR-1205/HOXA1 axis.

Authors:  Wei Zhong; Lei Bao; Yangyi Yuan; Yanzhi Meng
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.